These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 10374691
1. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas. Fujita M, Tomita S, Fukui H, Ueda Y, Fujimori T. J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691 [Abstract] [Full Text] [Related]
2. Change in telomerase activity during human colorectal carcinogenesis. Yoshida R, Kiyozuka Y, Ichiyoshi H, Senzaki H, Takada H, Hioki K, Tsubura A. Anticancer Res; 1999 Mar; 19(3B):2167-72. PubMed ID: 10472326 [Abstract] [Full Text] [Related]
3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Engelhardt M, Drullinsky P, Guillem J, Moore MA. Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582 [Abstract] [Full Text] [Related]
4. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma. Abe N, Watanabe T, Nakashima M, Masaki T, Mori T, Sugiyama M, Atomi Y. Hepatogastroenterology; 2001 Nov; 48(39):692-5. PubMed ID: 11462905 [Abstract] [Full Text] [Related]
5. Telomerase activity in different clinical staging of colorectal adenocarcinoma. Lukman K, Maskoen AM, Achmad TH, Hanafi B, Karnadihardja W. Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():491-7. PubMed ID: 10895200 [Abstract] [Full Text] [Related]
6. Telomerase activity and p53 gene mutation in familial polyposis coli. Ikeguchi M, Makino M, Kaibara N. Anticancer Res; 2000 May; 20(5C):3833-7. PubMed ID: 11268463 [Abstract] [Full Text] [Related]
7. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsuura Y, Yokoyama T. Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712 [Abstract] [Full Text] [Related]
8. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients. Ohuchida K, Mizumoto K, Ishikawa N, Sato N, Nagai E, Yamaguchi K, Takaishi H, Ide T, Tanaka M. Cancer; 2004 Nov 15; 101(10):2309-17. PubMed ID: 15476274 [Abstract] [Full Text] [Related]
9. Telomerase activity in stage II colorectal carcinoma. Kawanishi-Tabata R, Lopez F, Fratantonio S, Kim N, Goldblum J, Tubbs R, Elson P, Lavery I, Bukowski RM, Ganapathi R, Ganapathi MK. Cancer; 2002 Nov 01; 95(9):1834-9. PubMed ID: 12404275 [Abstract] [Full Text] [Related]
10. [Study of telomerase activity in colorectal carcinomas]. Zhao D, Zhang W, Jin S. Zhonghua Zhong Liu Za Zhi; 1998 May 01; 20(3):199-201. PubMed ID: 10921007 [Abstract] [Full Text] [Related]
11. [Telomerase activity in human gastric and colorectal cancer]. Chen W, Zhang Q, Wan D. Zhonghua Zhong Liu Za Zhi; 1998 Jul 01; 20(4):261-3. PubMed ID: 10920978 [Abstract] [Full Text] [Related]
12. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Engelhardt M, Albanell J, Drullinsky P, Han W, Guillem J, Scher HI, Reuter V, Moore MA. Clin Cancer Res; 1997 Oct 01; 3(10):1849-57. PubMed ID: 9815573 [Abstract] [Full Text] [Related]
13. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer]. Li LR, Wan DS, Pan ZZ, Hardingham J, Rieger N, Hewett P, Zhou ZW, Chen G. Ai Zheng; 2004 Nov 01; 23(11 Suppl):1502-7. PubMed ID: 15566667 [Abstract] [Full Text] [Related]
14. [Telomerase activity in colorectal cancer--a semi-quantitative procedure]. Ohki S, Satoh H, Watanabe F, Andoh Y, Nomizu T, Yoshida T, Tsuchiya A, Abe R, Yamaki Y. Gan To Kagaku Ryoho; 1998 Apr 01; 25 Suppl 3():469-74. PubMed ID: 9589055 [Abstract] [Full Text] [Related]
15. [Telomerase activity in colorectal carcinoma and its relationship to clinicopathological findings]. Iida A, Yamaguchi A, Ohtaki N, Goi T, Hirose K, Nakagawara G. Nihon Rinsho; 1998 May 01; 56(5):1214-7. PubMed ID: 9613125 [Abstract] [Full Text] [Related]
16. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Kumaki F, Kawai T, Hiroi S, Shinomiya N, Ozeki Y, Ferrans VJ, Torikata C. Hum Pathol; 2001 Feb 01; 32(2):188-95. PubMed ID: 11230706 [Abstract] [Full Text] [Related]
17. Quantitative analysis of hTERT mRNA expression in colorectal cancer. Niiyama H, Mizumoto K, Sato N, Nagai E, Mibu R, Fukui T, Kinoshita M, Tanaka M. Am J Gastroenterol; 2001 Jun 01; 96(6):1895-900. PubMed ID: 11419845 [Abstract] [Full Text] [Related]
18. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Edler D, Kressner U, Ragnhammar P, Johnston PG, Magnusson I, Glimelius B, Påhlman L, Lindmark G, Blomgren H. Clin Cancer Res; 2000 Feb 01; 6(2):488-92. PubMed ID: 10690528 [Abstract] [Full Text] [Related]
19. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization. Kammori M, Kanauchi H, Nakamura K, Kawahara M, Weber TK, Mafune K, Kaminishi M, Takubo K. Int J Oncol; 2002 Jan 01; 20(1):15-21. PubMed ID: 11743637 [Abstract] [Full Text] [Related]
20. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas]. Longchampt E, Lebret T, Molinie V, Bieche I, Botto H, Lidereau R. Prog Urol; 2003 Apr 01; 13(2):238-45. PubMed ID: 12765058 [Abstract] [Full Text] [Related] Page: [Next] [New Search]